FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection.

Stroke

From the University Clinic Würzburg, Departments of Neurology (P.K., E.G., M.K.S., G.S., C.K.) and Anesthesiology and Critical Care (M.B.), Rudolf Virchow Center, the Deutsche Forschungsgemeinschaft Research Center for Experimental Biomedicine (C.D., I.T., B.N.), Institute of Pharmacology and Toxicology, University of Würzburg (K.L.), Würzburg, Germany; Department of Neurology (K.G., A.M.H., S.G.M.), Institute of Physiology and Neuropathophysiology (S.G.M.), University of Münster, Germany; and University Clinic Frankfurt, Department of Neurology, Frankfurt, Germany (W.P.).

Published: November 2013

Background And Purpose: Lymphocytes are important players in the pathophysiology of acute ischemic stroke. The interaction of lymphocytes with endothelial cells and platelets, termed thrombo-inflammation, fosters microvascular dysfunction and secondary infarct growth. FTY720, a sphingosine-1-phosphate receptor modulator, blocks the egress of lymphocytes from lymphoid organs and has been shown to reduce ischemic neurodegeneration; however, the underlying mechanisms are unclear. We investigated the mode of FTY720 action in models of cerebral ischemia.

Methods: Transient middle cerebral artery occlusion (tMCAO) was induced in wild-type and lymphocyte-deficient Rag1(-/-) mice treated with FTY720 (1 mg/kg) or vehicle immediately before reperfusion. Stroke outcome was assessed 24 hours later. Immune cells in the blood and brain were counted by flow cytometry. The integrity of the blood-brain barrier was analyzed using Evans Blue dye. Thrombus formation was determined by immunohistochemistry and Western blot, and was correlated with cerebral perfusion.

Results: FTY720 significantly reduced stroke size and improved functional outcome in wild-type mice on day 1 and day 3 after transient middle cerebral artery occlusion. This protective effect was lost in lymphocyte-deficient Rag1(-/-) mice and in cultured neurons subjected to hypoxia. Less lymphocytes were present in the cerebral vasculature of FTY720-treated wild-type mice, which in turn reduced thrombosis and increased cerebral perfusion. In contrast, FTY720 was unable to prevent blood-brain barrier breakdown and transendothelial immune cell trafficking after transient middle cerebral artery occlusion.

Conclusions: Induction of lymphocytopenia and concomitant reduction of microvascular thrombosis are key modes of FTY720 action in stroke. In contrast, our findings in Rag1(-/-) mice and cultured neurons argue against direct neuroprotective effects of FTY720.

Download full-text PDF

Source
http://dx.doi.org/10.1161/STROKEAHA.113.002880DOI Listing

Publication Analysis

Top Keywords

transient middle
12
middle cerebral
12
cerebral artery
12
rag1-/- mice
12
fty720
8
acute ischemic
8
ischemic stroke
8
fty720 action
8
artery occlusion
8
lymphocyte-deficient rag1-/-
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!